MedTrace Logo

COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE)

NCT04379297 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1870

Last updated 2024-08-14

No results posted yet for this study

Summary

CON-VINCE (COvid-19 National survey for assessing VIral spread by Non-affected CarriErs) is a national, monocentric, and longitudinal study aiming to evaluate the spread dynamics of the COVID-19 disease within the Luxembourgish population. Participants who are clinically asymptomatic or present with only mild symptoms will be followed up longitudinally, regularly tested for SARS-CoV-2 by RT-PCR, antibody status, and subjected to an epidemiological, clinical and biological phenotyping to better understand the nature, dynamics of infectivity and spread of the virus in the population. CON-VINCE will also track the psychological and socio-economic impact of long-term containment measures on the general population.

Conditions

  • COVID19

Sponsors & Collaborators

  • Luxembourg National Research Funds

    collaborator UNKNOWN

  • University of Luxembourg

    collaborator OTHER

  • Centre Hospitalier du Luxembourg

    collaborator OTHER

  • TNS-Ilres

    collaborator UNKNOWN

  • Laboratoires Réunis

    collaborator UNKNOWN

  • BioneXt Lab

    collaborator UNKNOWN

  • Ketterthill

    collaborator UNKNOWN

  • Laboratoire National de santé

    collaborator UNKNOWN

  • Luxembourg Institute of Health

    lead OTHER_GOV

Principal Investigators

  • Rejko Krüger, Dr · Luxembourg Institute of Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-10
Primary Completion
2021-06-10
Completion
2022-09-30

Countries

  • Luxembourg

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04379297 on ClinicalTrials.gov